Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
65
ITRI Quote, Financials, Valuation and Earnings
Last price:
$136.67
Seasonality move
:
-5.91%
Day range:
$133.70 - $136.36
52-week range:
$90.11 - $136.46
Dividend yield:
0%
P/E ratio:
24.84x
P/S ratio:
2.57x
P/B ratio:
4.17x
Volume:
507.1K
Avg. volume:
528.7K
1-year change:
26.72%
Market cap:
$6.2B
Revenue:
$2.4B
EPS (TTM):
$5.48
Analysts' Opinion
-
Consensus RatingItron has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $134.18, Itron has an estimated downside of -1.43% from its current price of $136.13.
-
Price Target UpsideAccording to analysts, the highest upside price target is $155.00 representing 13.86% upside increase from its current price of $136.13.
Fair Value
-
According to the consensus of 10 analysts, Itron has -1.43% downside to fair value with a price target of $134.18 per share.
ITRI vs. S&P 500
-
Over the past 5 trading days, Itron has overperformed the S&P 500 by 0.96% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Itron does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Itron has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Itron reported revenues of $607.2M.
Earnings Growth
-
Itron has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Itron reported earnings per share of $1.42.
Enterprise value:
6.3B
EV / Invested capital:
--
Price / LTM sales:
2.57x
EV / EBIT:
19.79x
EV / Revenue:
2.60x
PEG ratio (5yr expected):
0.43x
EV / Free cash flow:
26.34x
Price / Operating cash flow:
26.07x
Enterprise value / EBITDA:
16.87x
Gross Profit (TTM):
$851.2M
Return On Assets:
7.79%
Net Income Margin (TTM):
10.34%
Return On Equity:
18.23%
Return On Invested Capital:
10.23%
Operating Margin:
12.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.8B | $2.3B | $2.4B | $603.4M | $607.2M | |
| Gross Profit | $543.3M | $762.9M | $851.2M | $205.4M | $217.2M | |
| Operating Income | $44.5M | $210.3M | $280.1M | $63M | $75.7M | |
| EBITDA | $39M | $266.9M | $376.3M | $79.9M | $99.9M | |
| Diluted EPS | -$0.50 | $3.48 | $5.48 | $1.12 | $1.42 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $792.5M | $902.1M | $1.1B | $1.9B | |
| Total Assets | $2.9B | $2.4B | $2.4B | $2.7B | $3.5B | |
| Current Liabilities | $909.6M | $501.6M | $536.6M | $578.3M | $983.4M | |
| Total Liabilities | $1.7B | $1.2B | $1.3B | $1.3B | $2B | |
| Total Equity | $1.2B | $1.2B | $1.2B | $1.4B | $1.5B | |
| Total Debt | $896.5M | $450.8M | $453.1M | $455.4M | $1.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $18.3M | $164.9M | $269M | $41.3M | $72.1M | |
| Cash From Investing | -$18.1M | -$56.8M | -$26.9M | -$41.1M | -$4.6M | |
| Cash From Financing | -$1.7M | -$2.3M | $580.3M | $1.1M | $1.8M | |
| Free Cash Flow | -$2.9M | $137.7M | $240.9M | $34.2M | $67.5M | |
ITRI
Sector
Market Cap
$6.2B
$83.5M
Price % of 52-Week High
99.76%
64.2%
Dividend Yield
0%
0%
Shareholder Yield
-1.4%
0.68%
1-Year Price Total Return
26.72%
-12.88%
Beta (5-Year)
1.348
0.814
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$134.99
200-day SMA
Buy
Level
$111.32
Bollinger Bands (100)
Buy
Level
101.6 - 124.96
Chaikin Money Flow
Buy
Level
930.5K
20-day SMA
Buy
Level
$132.48
Relative Strength Index (RSI14)
Buy
Level
72.94
ADX Line
Sell
Level
15.99
Williams %R
Sell
Level
-5.4455
50-day SMA
Buy
Level
$122.33
MACD (12, 26)
Buy
Level
36.97
25-day Aroon Oscillator
Buy
Level
84
On Balance Volume
Neutral
Level
1.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.8553)
Buy
CA Score
(Annual)
Level (0.0709)
Buy
Beneish M-Score
(Annual)
Level (-2.6314)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.6474)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.
Stock Forecast FAQ
In the current month, ITRI has received 8 Buy ratings 2 Hold ratings, and 0 Sell ratings. The ITRI average analyst price target in the past 3 months is $134.18.
-
Where Will Itron Stock Be In 1 Year?
According to analysts, the consensus estimate is that Itron share price will drop to $134.18 per share over the next 12 months.
-
What Do Analysts Say About Itron?
Analysts are divided on their view about Itron share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Itron is a Sell and believe this share price will rise from its current level to $110.00.
-
What Is Itron's Price Target?
The price target for Itron over the next 1-year time period is forecast to be $134.18 according to 10 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is ITRI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Itron is a Buy. 8 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ITRI?
You can purchase shares of Itron via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Itron shares.
-
What Is The Itron Share Price Today?
Itron was last trading at $136.67 per share. This represents the most recent stock quote for Itron. Yesterday, Itron closed at $136.13 per share.
-
How To Buy Itron Stock Online?
In order to purchase Itron stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
